These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1898749)

  • 1. Strategies for diagnosis and treatment of children at risk for occult bacteremia: clinical effectiveness and cost-effectiveness.
    Lieu TA; Schwartz JS; Jaffe DM; Fleisher GR
    J Pediatr; 1991 Jan; 118(1):21-9. PubMed ID: 1898749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and cost-effectiveness of outpatient strategies for management of febrile infants.
    Lieu TA; Baskin MN; Schwartz JS; Fleisher GR
    Pediatrics; 1992 Jun; 89(6 Pt 2):1135-44. PubMed ID: 1594366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of infants at risk for occult bacteremia: a decision analysis.
    Downs SM; McNutt RA; Margolis PA
    J Pediatr; 1991 Jan; 118(1):11-20. PubMed ID: 1986075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should blood cultures be obtained in the evaluation of young febrile children without evident focus of bacterial infection? A decision analysis of diagnostic management strategies.
    Kramer MS; Lane DA; Mills EL
    Pediatrics; 1989 Jul; 84(1):18-27. PubMed ID: 2740170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of febrile children in the age of the conjugate pneumococcal vaccine: a cost-effectiveness analysis.
    Lee GM; Fleisher GR; Harper MB
    Pediatrics; 2001 Oct; 108(4):835-44. PubMed ID: 11581433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of febrile neonates unlikely to have bacterial infections.
    Chiu CH; Lin TY; Bullard MJ
    Pediatr Infect Dis J; 1997 Jan; 16(1):59-63. PubMed ID: 9002103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occult bacteremia in young febrile children.
    Kuppermann N
    Pediatr Clin North Am; 1999 Dec; 46(6):1073-109. PubMed ID: 10629675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A revised decision analysis of strategies in the management of febrile children at risk for occult bacteremia.
    Yamamoto LG; Worthley RG; Melish ME; Seto DS
    Am J Emerg Med; 1998 Mar; 16(2):193-207. PubMed ID: 9517704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic administration to treat possible occult bacteremia in febrile children.
    Jaffe DM; Tanz RR; Davis AT; Henretig F; Fleisher G
    N Engl J Med; 1987 Nov; 317(19):1175-80. PubMed ID: 3309658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular versus oral antibiotic therapy for the prevention of meningitis and other bacterial sequelae in young, febrile children at risk for occult bacteremia.
    Fleisher GR; Rosenberg N; Vinci R; Steinberg J; Powell K; Christy C; Boenning DA; Overturf G; Jaffe D; Platt R
    J Pediatr; 1994 Apr; 124(4):504-12. PubMed ID: 8151462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neisseria meningitidis bacteremia in children: quantitation of bacteremia and spontaneous clinical recovery without antibiotic therapy.
    Sullivan TD; LaScolea LJ
    Pediatrics; 1987 Jul; 80(1):63-7. PubMed ID: 3110730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cost-effectiveness analysis of bacterial endocarditis prophylaxis for febrile children who have cardiac lesions and undergo urinary catheterization in the emergency department.
    Caviness AC; Cantor SB; Allen CH; Ward MA
    Pediatrics; 2004 May; 113(5):1291-6. PubMed ID: 15121944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temperature response to acetaminophen and risk of occult bacteremia: a case-control study.
    Mazur LJ; Jones TM; Kozinetz CA
    J Pediatr; 1989 Dec; 115(6):888-91. PubMed ID: 2585223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Febrile infants: predictors of bacteremia.
    Crain EF; Shelov SP
    J Pediatr; 1982 Nov; 101(5):686-9. PubMed ID: 7131141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergency department versus office setting and physician/patient kinship effects in the diagnostic and therapeutic choices of febrile children at risk for occult bacteremia.
    Yamamoto LG; Boychuk RB
    Hawaii Med J; 1997 Aug; 56(8):209-14. PubMed ID: 9293153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for recurrent fever after the discontinuation of empiric antibiotic therapy for fever and neutropenia in pediatric patients with a malignancy or hematologic condition.
    Jones GR; Konsler GK; Dunaway RP; Gold SH; Cooper HA; Wells RJ
    J Pediatr; 1994 May; 124(5 Pt 1):703-8. PubMed ID: 8176555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine testing in young febrile children: a risk-benefit analysis.
    Kramer MS; Tange SM; Drummond KN; Mills EL
    J Pediatr; 1994 Jul; 125(1):6-13. PubMed ID: 8021786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revising the decision analysis for febrile children at risk for occult bacteremia in a future era of widespread pneumococcal immunization.
    Yamamoto LG
    Clin Pediatr (Phila); 2001 Nov; 40(11):583-94. PubMed ID: 11758957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does culture confirmation of high-sensitivity rapid streptococcal tests make sense? A medical decision analysis.
    Webb KH
    Pediatrics; 1998 Feb; 101(2):E2. PubMed ID: 9445512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of fever without source in infants and children.
    Baraff LJ
    Ann Emerg Med; 2000 Dec; 36(6):602-14. PubMed ID: 11097701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.